You can plausibly say, today’s virtual reality is a descendent of smartphones. The affordable sensors, chips, and high-resolution displays critical to rendering a decent VR experience were engineered for iPhones and Galaxys not Rifts and Vives. Early on, VR pioneer Oculus built prototypes with 1080p AMOLED displays from Samsung Galaxy S4 smartphones. But after Facebook’s […]
Monthly Archives: November 2020
Medical researchers isolated a peptide (small protein molecule) from beetroot. The peptide is able to inhibit a particular enzyme that is responsible for the breakdown of messenger molecules in the body. Due to its particularly stable molecular structure and pharmacological properties, the beetroot peptide may be a good candidate for development of a drug to […]
-Reported positive top-line results from the Company’s ongoing Phase 1 CARBON trial evaluating the safety and efficacy of CTX110™, targeting CD19+ B-cell malignancies- – Received Rare Pediatric Disease designation from the U.S. Food and Drug Administration (FDA) for CTX001™ for sickle cell disease
ARTIFICIAL INTELLIGENCE AI Has Cracked a Key Mathematical Puzzle for Understanding Our WorldKaren Hao | MIT Technology Review “Partial differential equations can describe everything from planetary motion to plate tectonics, but they’re notoriously hard to solve. …[a new deep-learning technique for solving PDEs] is 1,000 times faster than traditional mathematical formulas, which would ease our […]
Scientists in Vienna have developed a new human tissue screening technique that has identified previously unknown genes involved in causing microcephaly, a rare genetic disorder, and that could one day be used to identify unknown genes tied to other conditions. In a study published Thursday in Science, researchers screened lab-grown human brain tissues for 172 […]
How do you introduce yourself, scientifically? My name is Daniel Arias and I am a public health scientist specializing in health systems and health financing. I think the inclusion of ‘scientist’ after public health is valuable—our work is grounded in theory, relies on systematic observation of the world, and is conducted with methodological rigor, yet […]
The same biochemical triggers that spur a “fight or flight” response when we encounter threats may help tumor cells to thrive.
A team of infectious disease researchers has developed a new method to identify virulence genes in Streptococcus pneumoniae, the leading cause of bacterial pneumonia. Using this technique in a mouse model of pneumonia, they were able to gain new insights into the progression of the disease and its interaction with the flu virus.
Researchers find a new way to generate T-cells faster, making immediate treatment with this therapy possible.